Medicines for Malaria Venture
Medicines for Malaria Venture is a not-for-profit public-private partnership that was established as a foundation in Switzerland in 1999. Its main mission is to reduce malaria in disease-endemic countries by developing and facilitating the delivery of antimalarial drugs.
History
MMV was launched in 1999, with initial seed funding of US$4 million from the Government of Switzerland, the Department for International Development, the Government of the Netherlands, the World Bank, and the Rockefeller Foundation.Governance
MMV is governed by a board of directors. The Chairman of MMV is Mr Alan Court. MMV has a board of directors in North America, an Expert Scientific Advisory Committee which helps to identify projects, an Access & Product Management Advisory Committee and a Global Safety Board which reviews projects.Projects
MMV's project portfolio states that their goals are:- Effective treatment against drug-resistant strains of Plasmodium falciparum
- The potential for intermittent treatments
- Safety for small children
- Safety in pregnancy
- Effective treatment against Plasmodium vivax
- Effective treatment against severe malaria
- and transmission-blocking treatment.